Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Hospitals Can Adapt to Supply Chain Disruptions

COVID-19 has brought increasingly disruptive ripple effects across each of the world’s industries, but healthcare has been hit particularly hard. In addition to managing the increased stressors associated directly with the pandemic, healthcare providers the world over are dealing with the fallout of severe disruptions throughout their supply chains. In uncertain periods such as this,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
How Hospitals Can Adapt to Supply Chain Disruptions

COVID-19 has brought increasingly disruptive ripple effects across each of the world’s industries, but healthcare has been hit particularly hard.

In addition to managing the increased stressors associated directly with the pandemic, healthcare providers the world over are dealing with the fallout of severe disruptions throughout their supply chains.

In uncertain periods such as this, TPC stands ready to assist its Member hospitals in finding agile solutions to these disruptions that allow operations to remain as close to normal as possible as we collectively work through the challenges set in front of us.

As COVID-19 Proves, Healthcare Providers Must Be Ready to Pivot at a Moment’s Notice

Though COVID-19 is far from the first disruptive force healthcare supply chains have been asked to navigate, it has presented some unique challenges.

It’s more important than ever to evaluate best practices in adapting and responding to these disruptions.

First, it’s critical to thoroughly review not only your own supply chain, but the state of key drugs, other products, and their manufacturers. The FDA has been diligent in working with manufacturers of both drugs and medical equipment to get an idea of exactly how disruptive this pandemic might be, and it’s important that you leverage that information as often as you can to formulate a plan of attack that addresses potential impacts on your own supply chain.

Proactive risk management plans, data sharing and collaboration can ensure you’re firmly on the front line in fighting these disruptions and continuing to provide the key services and quality care for your patients.

Several best practices have also been recommended during this pandemic, including:

  • Providing education regarding COVID-19 to staff.
  • Rationing masks and personal protective equipment and curtailing areas where these products are available for use.
  • Managing N-95 mask usage and creating a proactive plan regarding nurses who will use the masks, careful attention to reuse guidelines, and more.

TPC is Proud to Help Guide You Through Uncertainty

As uncertainty mounts in the face of these supply chain disruptions, TPC is, as always, committed to acting as your guide toward proactive, beneficial action and working to source new suppliers and evaluate innovative solutions to assist our Members in their time of need.

With TPC’s ongoing commitment to communication and support, you can be confident in your ability to navigate these temporary disruptions and continue providing the best possible care to your patients.

Disruptions are going to occur, and COVID-19 is far from the last – however, by being flexible in addressing these challenges, we can work together to find solutions, providing valuable support within the TPC Member family.

To learn more or reach out with any specific questions, visit tpc1.com.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Digital health mergers and acquisitions (M&A) along with venture capital (VC) activities are rapidly increasing. Tempus AI's $1.7 billion acquisition of Personalis is part of a larger trend that is influencing health system operators’ selection of vendors. With $7.4 billion in funding during the first half of 2026, the health-tech industry is undergoing significant transformation.

  • 01Tempus AI acquired Personalis for $1.7 billion.
  • 02Health-tech received $7.4 billion in funding in the first half of 2026.
  • 03M&A activities are influencing vendor choices for health system operators.

Jul 30, 2026

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

In the first half of 2026, digital health AI investments reached $7.4 billion as organizations like CMS, hospitals, and startups increased their adoption of AI. Significant moves include the establishment of a new CMS technology office and a $1.7 billion acquisition in cancer technology. These developments mark an enterprise-level commitment to advancing AI in healthcare.

  • 01Digital health AI investments reached $7.4 billion in H1 2026.
  • 02The CMS established a new technology office to advance healthcare AI.
  • 03A major acquisition in cancer technology totaled $1.7 billion.

Jul 30, 2026

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

Sensor networks and AI push structural health monitoring toward a $8.6 billion market by 2035

The global structural health monitoring (SHM) market is projected to surpass $8.6 billion by 2035. This growth is fueled by the integration of AI analytics, wireless sensor technologies, and the necessity to address aging infrastructure. The expansion reflects a widespread adoption of these technologies in various sectors.

  • 01The SHM market is expected to exceed $8.6 billion by 2035.
  • 02Advancements in AI-powered analytics and wireless sensors are key drivers of market growth.
  • 03Aging infrastructure is creating a demand for enhanced structural health monitoring solutions.

Jul 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512